Cargando…

Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe

WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Maponga, Charles Chiedza, Chikwinya, Takudzwa, Hove, Ropa, Madzikwa, Newman, Mazambara, Fine, Midzi, Stanley M, Mudzimu, Forward, Ndlovu, Misheck, Ngirande, William, Vengesayi, Ndanatseyi, Mhazo, Alison T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756290/
https://www.ncbi.nlm.nih.gov/pubmed/35022182
http://dx.doi.org/10.1136/bmjgh-2021-007548
_version_ 1784632539303903232
author Maponga, Charles Chiedza
Chikwinya, Takudzwa
Hove, Ropa
Madzikwa, Newman
Mazambara, Fine
Midzi, Stanley M
Mudzimu, Forward
Ndlovu, Misheck
Ngirande, William
Vengesayi, Ndanatseyi
Mhazo, Alison T
author_facet Maponga, Charles Chiedza
Chikwinya, Takudzwa
Hove, Ropa
Madzikwa, Newman
Mazambara, Fine
Midzi, Stanley M
Mudzimu, Forward
Ndlovu, Misheck
Ngirande, William
Vengesayi, Ndanatseyi
Mhazo, Alison T
author_sort Maponga, Charles Chiedza
collection PubMed
description WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations. Zimbabwe’s GGM-IF emerged from; (1) home-based expertise, (2) extensive local consultations and (3) effective incorporation into existing institutions. The GGM-IF committed to implementing a focused programme over a 5-year period from 2017 to 2022 with the expressed goal of improving transparency and accountability in the pharmaceutical sector as a key enabler to improve access to medicines. Midway through its projected lifespan, some notable achievements materialised attributed to key success drivers, including mutual collaboration with the Ministry of Health and Child Care’s existing Global Fund supported Quality Assurance Programme. Key challenges faced include limited funding for the programme, a shifting policy environment driven by a political transition and reorientation of priorities in the wake of the COVID-19 pandemic. This manuscript articulates 3-year operationalisation of Zimbabwe’s GGM-IF highlighting the success drivers, implementation challenges and lessons learnt.
format Online
Article
Text
id pubmed-8756290
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87562902022-01-26 Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe Maponga, Charles Chiedza Chikwinya, Takudzwa Hove, Ropa Madzikwa, Newman Mazambara, Fine Midzi, Stanley M Mudzimu, Forward Ndlovu, Misheck Ngirande, William Vengesayi, Ndanatseyi Mhazo, Alison T BMJ Glob Health Practice WHO launched the Good Governance for Medicines (GGM) programme in 2004 with the aim of fighting the problem of corruption in the pharmaceutical sector. Zimbabwe adopted the GGM programme in 2015 and developed its own implementation framework (GGM-IF) in 2017 based on the WHO global guidelines and recommendations. Zimbabwe’s GGM-IF emerged from; (1) home-based expertise, (2) extensive local consultations and (3) effective incorporation into existing institutions. The GGM-IF committed to implementing a focused programme over a 5-year period from 2017 to 2022 with the expressed goal of improving transparency and accountability in the pharmaceutical sector as a key enabler to improve access to medicines. Midway through its projected lifespan, some notable achievements materialised attributed to key success drivers, including mutual collaboration with the Ministry of Health and Child Care’s existing Global Fund supported Quality Assurance Programme. Key challenges faced include limited funding for the programme, a shifting policy environment driven by a political transition and reorientation of priorities in the wake of the COVID-19 pandemic. This manuscript articulates 3-year operationalisation of Zimbabwe’s GGM-IF highlighting the success drivers, implementation challenges and lessons learnt. BMJ Publishing Group 2022-01-12 /pmc/articles/PMC8756290/ /pubmed/35022182 http://dx.doi.org/10.1136/bmjgh-2021-007548 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Practice
Maponga, Charles Chiedza
Chikwinya, Takudzwa
Hove, Ropa
Madzikwa, Newman
Mazambara, Fine
Midzi, Stanley M
Mudzimu, Forward
Ndlovu, Misheck
Ngirande, William
Vengesayi, Ndanatseyi
Mhazo, Alison T
Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title_full Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title_fullStr Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title_full_unstemmed Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title_short Lessons learnt from implementing the Good Governance for Medicines Programme in Zimbabwe
title_sort lessons learnt from implementing the good governance for medicines programme in zimbabwe
topic Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756290/
https://www.ncbi.nlm.nih.gov/pubmed/35022182
http://dx.doi.org/10.1136/bmjgh-2021-007548
work_keys_str_mv AT mapongacharleschiedza lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT chikwinyatakudzwa lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT hoveropa lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT madzikwanewman lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT mazambarafine lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT midzistanleym lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT mudzimuforward lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT ndlovumisheck lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT ngirandewilliam lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT vengesayindanatseyi lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe
AT mhazoalisont lessonslearntfromimplementingthegoodgovernanceformedicinesprogrammeinzimbabwe